APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Microbial Therapeutic Product

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Microbial Therapeutic Product Industry Growth and Trends Forecast to 2032

Report ID 17401325012 January 2026114 pages

Choose your research edition.

Industry ResearchMicrobial Therapeutic Product Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Microbial Therapeutic Product Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Microbial Therapeutic Product Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Microbial Therapeutic Product Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Microbial Therapeutic Product Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

According to APO Research, the global Microbial Therapeutic Product market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Microbial Therapeutic Product is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Microbial Therapeutic Product is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Microbial Therapeutic Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Microbial Therapeutic Product market include Novartis, Roche, Eli Lilly and Company, Pfizer, Amgen Inc., Viatris, Sanofi S.A., Novo Nordisk A/S and Merck & Co. Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Microbial Therapeutic Product market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Microbial Therapeutic Product market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Microbial Therapeutic Product market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Microbial Therapeutic Product.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Microbial Therapeutic Product market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Microbial Therapeutic Product Market by Company

Novartis

Roche

Eli Lilly and Company

Pfizer

Amgen Inc.

Viatris

Sanofi S.A.

Novo Nordisk A/S

Merck & Co. Inc.

Intas Pharmaceuticals Ltd.

Dr. Reddy’s Laboratories Ltd.

Bristol-Myers Squibb Company

Boehringer Ingelheim

Biocon

Abbot Laboratories

Microbial Therapeutic Product Segment by Type

Single Use Pre-Filled Injection/Injector Pen

Multi-use Injectors

Others

Microbial Therapeutic Product Segment by Application

Oncology

Haematological Disorders

Immunological Disorders

Allergic Diseases

Metabolic Disorders

Infectious Diseases

Others

Microbial Therapeutic Product Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microbial Therapeutic Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Microbial Therapeutic Product and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microbial Therapeutic Product.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Microbial Therapeutic Product companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Microbial Therapeutic Product Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Microbial Therapeutic Product Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Microbial Therapeutic Product Market Share by Region (2021-2026) Table 4. Global Microbial Therapeutic Product Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Microbial Therapeutic Product Market Share by Region (2027-2032) Table 6. Global Microbial Therapeutic Product Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Microbial Therapeutic Product Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Microbial Therapeutic Product Market Size Share by Type (2021-2026) Table 9. Global Microbial Therapeutic Product Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Microbial Therapeutic Product Market Size Share Forecasted by Type (2027-2032) Table 11. North America Microbial Therapeutic Product Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Microbial Therapeutic Product Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Microbial Therapeutic Product Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Microbial Therapeutic Product Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Microbial Therapeutic Product Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Microbial Therapeutic Product Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Microbial Therapeutic Product Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Microbial Therapeutic Product Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Microbial Therapeutic Product Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Microbial Therapeutic Product Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Microbial Therapeutic Product Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Microbial Therapeutic Product Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Microbial Therapeutic Product Market Size Share by Application (2021-2026) Table 24. Global Microbial Therapeutic Product Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Microbial Therapeutic Product Market Size Share Forecasted by Application (2027-2032) Table 26. North America Microbial Therapeutic Product Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Microbial Therapeutic Product Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Microbial Therapeutic Product Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Microbial Therapeutic Product Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Microbial Therapeutic Product Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Microbial Therapeutic Product Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Microbial Therapeutic Product Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Microbial Therapeutic Product Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Microbial Therapeutic Product Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Microbial Therapeutic Product Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Microbial Therapeutic Product Industry Trends Table 37. Microbial Therapeutic Product Industry Drivers Table 38. Microbial Therapeutic Product Industry Opportunities and Challenges Table 39. Microbial Therapeutic Product Industry Restraints Table 40. Global Microbial Therapeutic Product Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Microbial Therapeutic Product Revenue Market Share by Company (2021-2026) Table 42. Global Microbial Therapeutic Product Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Microbial Therapeutic Product Key Company Headquarters & Area Served Table 44. Global Microbial Therapeutic Product Company, Product Type & Application Table 45. Global Microbial Therapeutic Product Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Microbial Therapeutic Product by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Novartis Company Information Table 49. Novartis Business Overview Table 50. Novartis Microbial Therapeutic Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Novartis Microbial Therapeutic Product Product Portfolio Table 52. Novartis Recent Development Table 53. Roche Company Information Table 54. Roche Business Overview Table 55. Roche Microbial Therapeutic Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Roche Microbial Therapeutic Product Product Portfolio Table 57. Roche Recent Development Table 58. Eli Lilly and Company Company Information Table 59. Eli Lilly and Company Business Overview Table 60. Eli Lilly and Company Microbial Therapeutic Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Eli Lilly and Company Microbial Therapeutic Product Product Portfolio Table 62. Eli Lilly and Company Recent Development Table 63. Pfizer Company Information Table 64. Pfizer Business Overview Table 65. Pfizer Microbial Therapeutic Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Pfizer Microbial Therapeutic Product Product Portfolio Table 67. Pfizer Recent Development Table 68. Amgen Inc. Company Information Table 69. Amgen Inc. Business Overview Table 70. Amgen Inc. Microbial Therapeutic Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Amgen Inc. Microbial Therapeutic Product Product Portfolio Table 72. Amgen Inc. Recent Development Table 73. Viatris Company Information Table 74. Viatris Business Overview Table 75. Viatris Microbial Therapeutic Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Viatris Microbial Therapeutic Product Product Portfolio Table 77. Viatris Recent Development Table 78. Sanofi S.A. Company Information Table 79. Sanofi S.A. Business Overview Table 80. Sanofi S.A. Microbial Therapeutic Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Sanofi S.A. Microbial Therapeutic Product Product Portfolio Table 82. Sanofi S.A. Recent Development Table 83. Novo Nordisk A/S Company Information Table 84. Novo Nordisk A/S Business Overview Table 85. Novo Nordisk A/S Microbial Therapeutic Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Novo Nordisk A/S Microbial Therapeutic Product Product Portfolio Table 87. Novo Nordisk A/S Recent Development Table 88. Merck & Co. Inc. Company Information Table 89. Merck & Co. Inc. Business Overview Table 90. Merck & Co. Inc. Microbial Therapeutic Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Merck & Co. Inc. Microbial Therapeutic Product Product Portfolio Table 92. Merck & Co. Inc. Recent Development Table 93. Intas Pharmaceuticals Ltd. Company Information Table 94. Intas Pharmaceuticals Ltd. Business Overview Table 95. Intas Pharmaceuticals Ltd. Microbial Therapeutic Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Intas Pharmaceuticals Ltd. Microbial Therapeutic Product Product Portfolio Table 97. Intas Pharmaceuticals Ltd. Recent Development Table 98. Dr. Reddy’s Laboratories Ltd. Company Information Table 99. Dr. Reddy’s Laboratories Ltd. Business Overview Table 100. Dr. Reddy’s Laboratories Ltd. Microbial Therapeutic Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Dr. Reddy’s Laboratories Ltd. Microbial Therapeutic Product Product Portfolio Table 102. Dr. Reddy’s Laboratories Ltd. Recent Development Table 103. Bristol-Myers Squibb Company Company Information Table 104. Bristol-Myers Squibb Company Business Overview Table 105. Bristol-Myers Squibb Company Microbial Therapeutic Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Bristol-Myers Squibb Company Microbial Therapeutic Product Product Portfolio Table 107. Bristol-Myers Squibb Company Recent Development Table 108. Boehringer Ingelheim Company Information Table 109. Boehringer Ingelheim Business Overview Table 110. Boehringer Ingelheim Microbial Therapeutic Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Boehringer Ingelheim Microbial Therapeutic Product Product Portfolio Table 112. Boehringer Ingelheim Recent Development Table 113. Biocon Company Information Table 114. Biocon Business Overview Table 115. Biocon Microbial Therapeutic Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Biocon Microbial Therapeutic Product Product Portfolio Table 117. Biocon Recent Development Table 118. Abbot Laboratories Company Information Table 119. Abbot Laboratories Business Overview Table 120. Abbot Laboratories Microbial Therapeutic Product Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Abbot Laboratories Microbial Therapeutic Product Product Portfolio Table 122. Abbot Laboratories Recent Development Table 123. North America Microbial Therapeutic Product Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Microbial Therapeutic Product Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Microbial Therapeutic Product Market Share by Country (2021-2026) Table 126. North America Microbial Therapeutic Product Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Microbial Therapeutic Product Market Share Forecast by Country (2027-2032) Table 128. Europe Microbial Therapeutic Product Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Microbial Therapeutic Product Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Microbial Therapeutic Product Market Share by Country (2021-2026) Table 131. Europe Microbial Therapeutic Product Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Microbial Therapeutic Product Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Microbial Therapeutic Product Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Microbial Therapeutic Product Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Microbial Therapeutic Product Market Share by Country (2021-2026) Table 136. Asia-Pacific Microbial Therapeutic Product Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Microbial Therapeutic Product Market Share Forecast by Country (2027-2032) Table 138. Latin America Microbial Therapeutic Product Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Microbial Therapeutic Product Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Microbial Therapeutic Product Market Share by Country (2021-2026) Table 141. Latin America Microbial Therapeutic Product Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Microbial Therapeutic Product Market Share Forecast by Country (2027-2032) Table 143. Middle East & Africa Microbial Therapeutic Product Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East & Africa Microbial Therapeutic Product Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East & Africa Microbial Therapeutic Product Market Share by Country (2021-2026) Table 146. Middle East & Africa Microbial Therapeutic Product Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East & Africa Microbial Therapeutic Product Market Share Forecast by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Microbial Therapeutic Product Product Image Figure 3. Global Microbial Therapeutic Product Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Microbial Therapeutic Product Market Size (2021-2032) & (US$ Million) Figure 5. Global Microbial Therapeutic Product Market Share by Region: 2025 VS 2032 Figure 6. Global Microbial Therapeutic Product Market Share by Region (2021-2032) Figure 7. North America Microbial Therapeutic Product Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Microbial Therapeutic Product Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Microbial Therapeutic Product Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Microbial Therapeutic Product Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Microbial Therapeutic Product Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Single Use Pre-Filled Injection/Injector Pen Image Figure 13. Global Single Use Pre-Filled Injection/Injector Pen Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Multi-use Injectors Image Figure 15. Global Multi-use Injectors Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Others Image Figure 17. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Microbial Therapeutic Product Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Microbial Therapeutic Product Market Share by Type 2025 VS 2032 Figure 20. North America Microbial Therapeutic Product Market Size Share by Type (2021-2032) Figure 21. Europe Microbial Therapeutic Product Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Microbial Therapeutic Product Market Size Share by Type (2021-2032) Figure 23. Latin America Microbial Therapeutic Product Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Microbial Therapeutic Product Market Size Share by Type (2021-2032) Figure 25. Oncology Image Figure 26. Global Oncology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Haematological Disorders Image Figure 28. Global Haematological Disorders Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Immunological Disorders Image Figure 30. Global Immunological Disorders Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Allergic Diseases Image Figure 32. Global Allergic Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Metabolic Disorders Image Figure 34. Global Metabolic Disorders Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Infectious Diseases Image Figure 36. Global Infectious Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Others Image Figure 38. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Global Microbial Therapeutic Product Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Microbial Therapeutic Product Market Share by Application 2025 VS 2032 Figure 41. North America Microbial Therapeutic Product Market Size Share by Application (2021-2032) Figure 42. Europe Microbial Therapeutic Product Market Size Share by Application (2021-2032) Figure 43. Asia-Pacific Microbial Therapeutic Product Market Size Share by Application (2021-2032) Figure 44. Latin America Microbial Therapeutic Product Market Size Share by Application (2021-2032) Figure 45. Middle East and Africa Microbial Therapeutic Product Market Size Share by Application (2021-2032) Figure 46. Global Top 5 and 10 Microbial Therapeutic Product Players Market Share by Revenue in 2025 Figure 47. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 48. North America Microbial Therapeutic Product Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. North America Microbial Therapeutic Product Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. North America Microbial Therapeutic Product Market Share by Country (2021-2032) Figure 51. Europe Microbial Therapeutic Product Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Microbial Therapeutic Product Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Microbial Therapeutic Product Market Share by Country (2021-2032) Figure 54. Asia-Pacific Microbial Therapeutic Product Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Asia-Pacific Microbial Therapeutic Product Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Asia-Pacific Microbial Therapeutic Product Market Share by Country (2021-2032) Figure 57. Latin America Microbial Therapeutic Product Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Microbial Therapeutic Product Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Microbial Therapeutic Product Market Share by Country (2021-2032) Figure 60. Middle East & Africa Microbial Therapeutic Product Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Middle East & Africa Microbial Therapeutic Product Market Share by Country: 2021 VS 2025 VS 2032 Figure 62. Middle East & Africa Microbial Therapeutic Product Market Share by Country (2021-2032) Figure 63. Years Considered Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Single Use Pre-Filled Injection/Injector Pen
  • Multi-use Injectors
  • Others
Applications
  • Oncology
  • Haematological Disorders
  • Immunological Disorders
  • Allergic Diseases
  • Metabolic Disorders
  • Infectious Diseases
  • Others
Companies covered
  • Novartis
  • Roche
  • Eli Lilly and Company
  • Pfizer
  • Amgen Inc.
  • Viatris
  • Sanofi S.A.
  • Novo Nordisk A/S
  • Merck & Co. Inc.
  • Intas Pharmaceuticals Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • Bristol-Myers Squibb Company
  • Boehringer Ingelheim
  • Biocon
  • Abbot Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Microbial Therapeutic Product Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Microbial Therapeutic Product Market Size by Region (2021-2032)
  5. 1.4.1 Global Microbial Therapeutic Product Market Size by Region (2021-2026)
  6. 1.4.2 Global Microbial Therapeutic Product Market Size by Region (2027-2032)
  7. 1.5 Key Regions Microbial Therapeutic Product Market Size (2021-2032)
  8. 1.5.1 North America Microbial Therapeutic Product Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Microbial Therapeutic Product Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Microbial Therapeutic Product Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Microbial Therapeutic Product Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Microbial Therapeutic Product Market Size Growth Rate (2021-2032)
2 Microbial Therapeutic Product Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Single Use Pre-Filled Injection/Injector Pen
  3. 2.1.2 Multi-use Injectors
  4. 2.1.3 Others
  5. 2.2 Global Microbial Therapeutic Product Market Size by Type
  6. 2.2.1 Global Microbial Therapeutic Product Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Microbial Therapeutic Product Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Microbial Therapeutic Product Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Microbial Therapeutic Product Market Size by Regions
  10. 2.3.1 North America Microbial Therapeutic Product Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Microbial Therapeutic Product Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Microbial Therapeutic Product Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Microbial Therapeutic Product Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Microbial Therapeutic Product Market Size Breakdown by Type (2021-2026)
3 Microbial Therapeutic Product Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Oncology
  3. 3.1.2 Haematological Disorders
  4. 3.1.3 Immunological Disorders
  5. 3.1.4 Allergic Diseases
  6. 3.1.5 Metabolic Disorders
  7. 3.1.6 Infectious Diseases
  8. 3.1.7 Others
  9. 3.2 Global Microbial Therapeutic Product Market Size by Application
  10. 3.2.1 Global Microbial Therapeutic Product Market Size Overview by Application (2021-2032)
  11. 3.2.2 Global Microbial Therapeutic Product Historic Market Size Review by Application (2021-2026)
  12. 3.2.3 Global Microbial Therapeutic Product Market Size Forecasted by Application (2027-2032)
  13. 3.3 Global Microbial Therapeutic Product Market Size by Regions
  14. 3.3.1 North America Microbial Therapeutic Product Market Size Breakdown by Application (2021-2026)
  15. 3.3.2 Europe Microbial Therapeutic Product Market Size Breakdown by Application (2021-2026)
  16. 3.3.3 Asia-Pacific Microbial Therapeutic Product Market Size Breakdown by Application (2021-2026)
  17. 3.3.4 South America Microbial Therapeutic Product Market Size Breakdown by Application (2021-2026)
  18. 3.3.5 Middle East and Africa Microbial Therapeutic Product Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Microbial Therapeutic Product Industry Trends
  2. 4.2 Microbial Therapeutic Product Industry Drivers
  3. 4.3 Microbial Therapeutic Product Industry Opportunities and Challenges
  4. 4.4 Microbial Therapeutic Product Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Microbial Therapeutic Product Revenue (2021-2026)
  2. 5.2 Global Microbial Therapeutic Product Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Microbial Therapeutic Product Key Company Headquarters & Area Served
  4. 5.4 Global Microbial Therapeutic Product Company, Product Type & Application
  5. 5.5 Global Microbial Therapeutic Product Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Microbial Therapeutic Product Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Microbial Therapeutic Product Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Microbial Therapeutic Product Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Microbial Therapeutic Product Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Microbial Therapeutic Product Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Roche
  8. 6.2.1 Roche Company Information
  9. 6.2.2 Roche Business Overview
  10. 6.2.3 Roche Microbial Therapeutic Product Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Roche Microbial Therapeutic Product Product Portfolio
  12. 6.2.5 Roche Recent Developments
  13. 6.3 Eli Lilly and Company
  14. 6.3.1 Eli Lilly and Company Company Information
  15. 6.3.2 Eli Lilly and Company Business Overview
  16. 6.3.3 Eli Lilly and Company Microbial Therapeutic Product Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Eli Lilly and Company Microbial Therapeutic Product Product Portfolio
  18. 6.3.5 Eli Lilly and Company Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Microbial Therapeutic Product Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Microbial Therapeutic Product Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Amgen Inc.
  26. 6.5.1 Amgen Inc. Company Information
  27. 6.5.2 Amgen Inc. Business Overview
  28. 6.5.3 Amgen Inc. Microbial Therapeutic Product Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Amgen Inc. Microbial Therapeutic Product Product Portfolio
  30. 6.5.5 Amgen Inc. Recent Developments
  31. 6.6 Viatris
  32. 6.6.1 Viatris Company Information
  33. 6.6.2 Viatris Business Overview
  34. 6.6.3 Viatris Microbial Therapeutic Product Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Viatris Microbial Therapeutic Product Product Portfolio
  36. 6.6.5 Viatris Recent Developments
  37. 6.7 Sanofi S.A.
  38. 6.7.1 Sanofi S.A. Company Information
  39. 6.7.2 Sanofi S.A. Business Overview
  40. 6.7.3 Sanofi S.A. Microbial Therapeutic Product Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Sanofi S.A. Microbial Therapeutic Product Product Portfolio
  42. 6.7.5 Sanofi S.A. Recent Developments
  43. 6.8 Novo Nordisk A/S
  44. 6.8.1 Novo Nordisk A/S Company Information
  45. 6.8.2 Novo Nordisk A/S Business Overview
  46. 6.8.3 Novo Nordisk A/S Microbial Therapeutic Product Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Novo Nordisk A/S Microbial Therapeutic Product Product Portfolio
  48. 6.8.5 Novo Nordisk A/S Recent Developments
  49. 6.9 Merck & Co. Inc.
  50. 6.9.1 Merck & Co. Inc. Company Information
  51. 6.9.2 Merck & Co. Inc. Business Overview
  52. 6.9.3 Merck & Co. Inc. Microbial Therapeutic Product Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Merck & Co. Inc. Microbial Therapeutic Product Product Portfolio
  54. 6.9.5 Merck & Co. Inc. Recent Developments
  55. 6.10 Intas Pharmaceuticals Ltd.
  56. 6.10.1 Intas Pharmaceuticals Ltd. Company Information
  57. 6.10.2 Intas Pharmaceuticals Ltd. Business Overview
  58. 6.10.3 Intas Pharmaceuticals Ltd. Microbial Therapeutic Product Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Intas Pharmaceuticals Ltd. Microbial Therapeutic Product Product Portfolio
  60. 6.10.5 Intas Pharmaceuticals Ltd. Recent Developments
  61. 6.11 Dr. Reddy’s Laboratories Ltd.
  62. 6.11.1 Dr. Reddy’s Laboratories Ltd. Company Information
  63. 6.11.2 Dr. Reddy’s Laboratories Ltd. Business Overview
  64. 6.11.3 Dr. Reddy’s Laboratories Ltd. Microbial Therapeutic Product Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Dr. Reddy’s Laboratories Ltd. Microbial Therapeutic Product Product Portfolio
  66. 6.11.5 Dr. Reddy’s Laboratories Ltd. Recent Developments
  67. 6.12 Bristol-Myers Squibb Company
  68. 6.12.1 Bristol-Myers Squibb Company Company Information
  69. 6.12.2 Bristol-Myers Squibb Company Business Overview
  70. 6.12.3 Bristol-Myers Squibb Company Microbial Therapeutic Product Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Bristol-Myers Squibb Company Microbial Therapeutic Product Product Portfolio
  72. 6.12.5 Bristol-Myers Squibb Company Recent Developments
  73. 6.13 Boehringer Ingelheim
  74. 6.13.1 Boehringer Ingelheim Company Information
  75. 6.13.2 Boehringer Ingelheim Business Overview
  76. 6.13.3 Boehringer Ingelheim Microbial Therapeutic Product Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Boehringer Ingelheim Microbial Therapeutic Product Product Portfolio
  78. 6.13.5 Boehringer Ingelheim Recent Developments
  79. 6.14 Biocon
  80. 6.14.1 Biocon Company Information
  81. 6.14.2 Biocon Business Overview
  82. 6.14.3 Biocon Microbial Therapeutic Product Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Biocon Microbial Therapeutic Product Product Portfolio
  84. 6.14.5 Biocon Recent Developments
  85. 6.15 Abbot Laboratories
  86. 6.15.1 Abbot Laboratories Company Information
  87. 6.15.2 Abbot Laboratories Business Overview
  88. 6.15.3 Abbot Laboratories Microbial Therapeutic Product Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Abbot Laboratories Microbial Therapeutic Product Product Portfolio
  90. 6.15.5 Abbot Laboratories Recent Developments
7 North America
  1. 7.1 North America Microbial Therapeutic Product Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Microbial Therapeutic Product Market Size by Country (2021-2026)
  3. 7.3 North America Microbial Therapeutic Product Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Microbial Therapeutic Product Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Microbial Therapeutic Product Market Size by Country (2021-2026)
  3. 8.3 Europe Microbial Therapeutic Product Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Microbial Therapeutic Product Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Microbial Therapeutic Product Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Microbial Therapeutic Product Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Microbial Therapeutic Product Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Microbial Therapeutic Product Market Size by Country (2021-2026)
  3. 10.3 South America Microbial Therapeutic Product Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Microbial Therapeutic Product Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Microbial Therapeutic Product Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Microbial Therapeutic Product Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst